Dandekar Atul

Maze Therapeutics, Inc. · CSBO

Dandekar Atul is listed in filings as CSBO at Maze Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Maze Therapeutics, Inc. (MAZE). The current snapshot covers public activity from Sep 24, 2025 to Jun 2, 2026. Reported amounts are shown as $197.6K to $86.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceLast Price
Maze Therapeutics, Inc.MAZE$190k7.5k sharesSellApr 29, 2026$25.37$27.17
Maze Therapeutics, Inc.MAZE$196k6.7k sharesSellMar 30, 2026$29.26$27.17
Maze Therapeutics, Inc.MAZE$24k790 sharesSellMar 30, 2026$30.02$27.17
Maze Therapeutics, Inc.MAZE$154k3.5k sharesSellJan 29, 2026$44.04$27.17
Maze Therapeutics, Inc.MAZE$126k2.8k sharesSellJan 29, 2026$45.01$27.17
Maze Therapeutics, Inc.MAZE$52k1.2k sharesSellJan 29, 2026$43.18$27.17
Maze Therapeutics, Inc.MAZE$4k100 sharesSellDec 30, 2025$40.36$27.17
Maze Therapeutics, Inc.MAZE$3M66.4k sharesSellDec 29, 2025$40.51$27.17
Maze Therapeutics, Inc.MAZE$248k6k sharesSellDec 29, 2025$41.13$27.17